way 100135 has been researched along with malondialdehyde in 1 studies
Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (malondialdehyde) | Trials (malondialdehyde) | Recent Studies (post-2010) (malondialdehyde) |
---|---|---|---|---|---|
143 | 0 | 34 | 27,849 | 1,405 | 13,922 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arcaro, V; Ballabeni, V; Barocelli, E; Bertoni, S; Cantoni, AM; Domenichini, G; Flammini, L; Rapalli, A; Saccani, F; Tognolini, M; Vivo, V | 1 |
1 other study(ies) available for way 100135 and malondialdehyde
Article | Year |
---|---|
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Buspirone; Female; Heme Oxygenase-1; Interleukin-1beta; Intestinal Mucosa; Intestines; Malondialdehyde; Membrane Proteins; Mice; Nicotinic Antagonists; Peroxidase; Piperazines; Receptor, Serotonin, 5-HT1A; Reperfusion Injury; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Tumor Necrosis Factor-alpha | 2014 |